Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) has suddenly landed back on traders’ radars. After months of drifting as a tiny, cash‑rich micro‑cap biotech, the stock exploded higher at the start of December 2025 – just weeks after the company killed its lead drug program and launched a strategic review. This article walks through the latest SNSE stock price moves, the full 2025 news timeline, the strategic review, analyst forecasts, and the key risks around this highly speculative name. It is informational only and not investment advice. SNSE stock price today: how high did Sensei Biotherapeutics jump? As of the regular session
